Calvit LC Tablet is a calcium and vitamin supplement developed by MARC LAB. It is designed to improve calcium deficiency, strengthen bones and the spine, and fulfil the body's calcium requirements. The tablet contains essential nutrients such as calcium, vitamin D3, and L-lysine, which are helpful in the formation of bones. It ensures the proper supply of calcium required for bone formation and helps prevent bone breakage, especially in conditions like osteoporosis.
Key Ingredients:- Calcium carbonates 1250mg + Levocarnitine 150mg + Vitamin E 200 I.U + Vitamin D3 250 I.U
Key Benefits:- Calvit LC Tablet contains essential minerals and nutrients that are beneficial for bone health. Calcium is crucial for the formation and maintenance of strong bones. Vitamin D3 helps in the absorption of calcium and promotes bone mineralization
- Calvit LC Tablet is used to prevent and treat calcium deficiency. It ensures an adequate supply of calcium to the bones, which is essential for their proper functioning
- Osteoporosis is a condition characterized by weak and brittle bones. Calvit LC Tablet can be beneficial in preventing and managing osteoporosis by providing the necessary nutrients for bone health
- Calvit LC Tablet contains vitamin D3, which is important for maintaining optimal vitamin D levels in the body. Vitamin D deficiency can lead to various health issues, including bone problems. Supplementing with vitamin D3 can help prevent and treat vitamin D deficiency
Good to know:Calvit LC Tablet is suitable for use during pregnancy and breastfeeding.
Effects of Deficiency:- Calcium and vitamin D3 deficiency
Product Form:Tablet
Suitable for:Male/Female
Directions for Use:Usually, one or two tablets to be taken in one day orally with lukewarm or normal water as suggested by a healthcare professional
Safety Information:- Read the label carefully before use
- Store in a cool and dry place
- Keep out of reach of children
Quick Tips:Include calcium-rich foods in your diet, such as dairy products, leafy greens, and fortified foods.
